Anthera Announces Expansion of Screening in European Sites in Phase 3 RESULT Clinical Study of Sollpura
Study is being conducted in the US, Europe, and Israel Top line data expected end of 2017 or early 2018 HAYWARD, Calif., July 06, 2017 (GLOBE NEWSWIRE) -- Anthera (Nasdaq:ANTH) today announced that it has commenced screening in Europe in the RESULT Phase 3 …